FDA Adverse Event Injury Summary report: N

PROMUS PREMIER?

MDR report key: 3953045 · Received July 23, 2014

Report

Report Number
2134265-2014-04267
Event Type
Injury
Date Received
July 23, 2014
Date of Event
June 26, 2014
Report Date
June 26, 2014
Manufacturer
BOSTON SCIENTIFIC - GALWAY
Product Code
NIQ
PMA / PMN Number
P110010
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

(B)(4).DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. A REVIEW OF THE BATCH HISTORY, HISTORICAL TRENDING, AND SIMILAR COMPLAINT TRENDING REVIEW FOR THE PRODUCT FAMILY WILL BE CONDUCTED. IF THERE IS ANY FURTHER RELEVANT INFORMATION FROM THAT REVIEW, A SUPPLEMENTAL MEDWATCH WILL BE FILED.(B)(4).

Description of Event or Problem · 1

IT WAS REPORTED THAT STENT DAMAGE AND DISLODGEMENT OCCURRED.THE 95% STENOSED AND HEAVILY CALCIFIED TARGET LESION WAS LOCATED IN THE DISTAL LEFT MAIN (LM) AND OSTIAL LEFT CIRCUMFLEX (LCX) ARTERY. ROTABLATION OF THE DISTAL LM AND OSTIAL LEFT ANTERIOR DESCENDING (LAD) ARTERY WERE PERFORMED WITH SUBSEQUENT PLACEMENT OF A 4.0X16MM PROMUS PREMIER STENT IN THE DISTAL LM AND PROXIMAL LAD ARTERY. THE LESION WAS PRE-DILATED WITH SEVERAL APEX AND NC QUANTUM APEX BALLOONS. THE PHYSICIAN THEN USED A GUIDE WIRE TO CROSS THROUGH THAT STENT'S SIDE CELLS, IN THE MID STENT AND INTO THE LCX.THE SIDE CELL WAS PRE-DILATED WITH A BALLOON, BUT THE 3.50X12MM PROMUS PREMIER WAS NOT ABLE TO CROSS. UPON REMOVAL, THE STENT HAD DISLODGED AND WAS DISCOVERED IN THE HUB AREA OF THE GUIDE WITH DAMAGE NOTED. THE PROCEDURE WAS COMPLETED WITH ANOTHER OF THE SAME DEVICE DEPLOYED IN THE PROXIMAL LCX. NO ADDITIONAL PATIENT COMPLICATIONS WERE REPORTED AND THE PATIENT'S STATUS IS FINE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
431060 PROMUS PREMIER? STENT, CORONARY, DRUG-ELUTING NIQ BOSTON SCIENTIFIC - GALWAY H7493952812350 16763726

Patients

Seq Age Sex Outcome Treatment
1